^
Association details:
Biomarker:No biomarker
Cancer:Soft Tissue Sarcoma
Drug:Torisel (temsirolimus) (mTOR inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Published date:
03/29/2022
Excerpt:
Soft Tissue Sarcoma...Other recommended regimens...Vinorelbine/cyclophosphamide/temsirolimus
Secondary therapy:
VC